Trichomonal vaginitis: what should be done?

The lack of effectiveness of antibacterial and anti-in­flammatory therapy dictates the need to find new ways of treating mixed inflammatory diseases of the vagina in women with the use of new generation antibiotics. Mate­rials and methods of research. There were 72 patients aged 17 - 36 years with trichomonas vaginitis living in the city of Zaporizhzhya under observation. All women un­derwent a general clinical examination, three times (up to, 2 weeks and 3 months after the start of treatment) microscopic and bacteriological examination of vaginal discharge. The effectiveness of therapy was evaluated 3 months after the start of treatment. Results of the study and their discussion. Patients with trichomonas vagini­tis have profound disorders of the relationship between obligate and pathogenic microorganisms, which contrib­utes to the recurrence of the pathological process and deterioration of quality of life. Conclusions: in the treat­ment of trichomonas vaginitis, the effectiveness of a drug containing ornidazole is better than that of metronidazole. Combined use of antibacterial drugs with ornidazole and ornidazole, neomycin sulfate, nystatin, prednisolone, with broad antibacterial properties and activity against Trichomonas vaginalis, Entamoeba histolytica, Giardia lacbia intestisis, Fardi intubisides (Fardium intestisis, fid- ium intestisis) and anaerobic cocci, effectively normalize the vaginal microflora indices in bacterial - fungal - tricho­monas vaginitis, shorten the treatment time, prevent the development of relapses in the future, thereby improving the quality of life of patients.